Bruker

Yahoo Finance • 11 days ago

How The Bruker (BRKR) Story Is Shifting As Growth Hopes Meet Margin And Helium Risks

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Bruker’s fair value estimate has been trimmed slightly from US$48.43 to US$47.86 per share, signaling a modest reset in modeled up... Full story

Yahoo Finance • 11 days ago

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

Thierry Bernard BILLERICA, Mass., April 01, 2026--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an internat... Full story

Yahoo Finance • 13 days ago

3 Stocks Under $50 We Approach with Caution

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale adv... Full story

Yahoo Finance • 13 days ago

Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries

Seer, Inc. 23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer's Proteograph® Product Suite REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leader in deep, unbiased proteomic insigh... Full story

Yahoo Finance • 16 days ago

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as investors reacted to escalating uncertainty tied to the U.S.-Iran conflict and poli... Full story

Yahoo Finance • 20 days ago

Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4

Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Strategy lagged the Russell Midcap® Growth Index... Full story

Yahoo Finance • 26 days ago

Will Bruker (BRKR) be Able to Rebound?

Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here. The Fund seeks to invest in companies that possess franchise ch... Full story

Yahoo Finance • 2 months ago

Nanorobotics Market Competitive Landscape Report 2025: Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Company Logo The nano robotics market, valued at USD 9.36 billion in 2025, is projected to surge to USD 22.16 billion by 2033, with a CAGR of 11.37%. Key growth drivers include rising personalized healthcare applications, investments enha... Full story

Yahoo Finance • 2 months ago

3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players

Company Logo The global 3D protein structure analysis market is rapidly expanding due to growing demand in drug development, personalized medicine, and biotech research. Key opportunities include advancements in AI and cloud computing, in... Full story

Yahoo Finance • 2 months ago

BRKR Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Bruker Corp (Symbol: BRKR) crossed below their 200 day moving average of $40.13, changing hands as low as $36.55 per share. Bruker Corp shares are currently trading off about 10.3% on the day. The chart... Full story

Yahoo Finance • 2 months ago

Bruker reports mixed Q4 results; initiates FY26 outlook

* Bruker press release [https://seekingalpha.com/pr/20397272-bruker-reports-fourth-quarter-and-full-year-2025-financial-results] (BRKR [https://seekingalpha.com/symbol/BRKR]): Q4 Non-GAAP EPS of $0.59 misses by $0.07. * Revenue of $977... Full story

Yahoo Finance • 2 months ago

PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co

This article first appeared on GuruFocus. Insights from the Fourth Quarter 2025 13F Filing PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of 2025, offering a glimpse into its strategic in... Full story

Yahoo Finance • 4 months ago

Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide

Key Points Utah-based Grandeur Peak Global Advisors sold 709,697 shares of Bruker in the third quarter. The estimated position value declined by $29.54 million from the previous period. As of September 30, the fund reported holding 34,097... Full story

Yahoo Finance • 4 months ago

Hedge funds short healthcare providers as subsidies debate intensifies

By Nell Mackenzie LONDON, Dec 22 (Reuters) - Hedge funds last week sold more U.S. healthcare stocks than they bought for the ​first time in 14 weeks, Goldman Sachs said in a note ‌on Friday, as expiring subsidies leave lawmakers scramblin... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index and the State Stree PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

AbCellera settles patent litigation with Bruker over microfluidic device tech

[The Patent Application Process Important Paperwork and Necessary Tools for Success] * Bruker Corp. (BRKR [https://seekingalpha.com/symbol/BRKR]) will pay AbCellera Biologics (ABCL [https://seekingalpha.com/symbol/ABCL]) $36M plus futur... Full story

Yahoo Finance • 4 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

VANCOUVER, British Columbia, December 18, 2025--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with Bruker Corporation, resolving the patent litigation between t... Full story

Yahoo Finance • 4 months ago

BBH Select Series – Mid Cap Fund Sold Bruker Corporation (BRKR) Due to Policy Uncertainty

Brown Brothers Harriman, an investment management company, released its Q3 2025 investor letter for the BBH Select Series - Mid Cap Fund. A copy of the same can be downloaded here. In the quarter, the fund decreased by -0.9% on a total ret... Full story

Yahoo Finance • 5 months ago

Galvanize Therapeutics Appoints Laura Francis to its Board of Directors

REDWOOD CITY, Calif., Nov. 24, 2025 /PRNewswire/ -- Galvanize ("Galvanize") Therapeutics, Inc., a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease, today ann... Full story

Yahoo Finance • 5 months ago

Michael Burry's Bets Against AI Stocks Nvidia and Palantir: What Investors Should Know

Key Points The S&P 500 and tech-heavy Nasdaq Composite indexes declined about 1.6% and 3.0%, respectively, this week. This week, shares of AI chip leader Nvidia declined 7.1%, and shares of Palantir, which operates an AI-driven data analy... Full story